Anti-TNF antibodies associated with different risk of latent tuberculosis activation.
Michele
M
Hooper
Eric
E
Chi
D000906:Antibodies / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects; D018124:Receptors, Tumor Necrosis Factor; D014397:Tuberculosis, Pulmonary / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000906:Antibodies; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept